Health care services provider Encompass Health (NYSE:EHC) will be announcing earnings results tomorrow after the bell. Here’s what investors should know.
Encompass Health beat analysts’ revenue expectations by 1.8% last quarter, reporting revenues of $1.35 billion, up 11.9% year on year. It was a strong quarter for the company, with a solid beat of analysts’ same-store sales estimates and a decent beat of analysts’ full-year EPS guidance estimates.
Is Encompass Health a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Encompass Health’s revenue to grow 10.7% year on year to $1.38 billion, improving from the 9.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.02 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Encompass Health has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.4% on average.
Looking at Encompass Health’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Centene delivered year-on-year revenue growth of 3.4%, beating analysts’ expectations by 4.4%, and Quest reported revenues up 14.6%, topping estimates by 1.8%. Quest traded up 5% following the results.
Read our full analysis of Centene’s results here and Quest’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 2.7% on average over the last month. Encompass Health is up 10.5% during the same time and is heading into earnings with an average analyst price target of $116.75 (compared to the current share price of $101.16).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.